Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases

NCT02230306 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped closed due to slow accrual

Conditions

Active Melanoma Brain Metastases

Interventions

DRUG: Cobimetinib
DRUG: Vemurafenib

Sponsor

Melissa Burgess, MD

Collaborators

[object Object]